Clinical Trial: Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Study Status: Completed
Recruit Status: RECRUITING
Condition: Sensorineural Hearing Loss, Bilateral
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2 Trial of AAVAnc80-hOTOF Gene Therapy in Individuals With Sensorineural Hearing Loss Due to Biallelic Otoferlin Gene Mutations
Brief Summary:
Part A of this trial will evaluate the safety and tolerability of a single unilateral administration of one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos delivery device to safely achieve the intended product performance.
Read more